Melanoma S2000
Study #S2000A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab Vs Ipilimumab + Nivolumab in BRAF V600-Mutant Melanoma with Brain Metastases
Back To Clinical Trials NCI Database Entry
A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab Vs Ipilimumab + Nivolumab in BRAF V600-Mutant Melanoma with Brain Metastases
Back To Clinical Trials NCI Database Entry